Rabacfosadine

CAS: 859209-74-8

Ref. 3D-JJB20974

Produktinformation

• Name: Rabacfosadine
• Synonyme: L-Alanine, N,N′-[[[2-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]ethoxy]methyl]phosphinylidene]bis-, diethyl ester, GS 9219, N,N′-[[[2-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]ethoxy]methyl]phosphinylidene]bis[L-alanine] 1,1′-ethyl ester, L-Alanine, N,N′-[[[2-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]ethoxy]methyl]phosphinylidene]bis-, 1,1′-ethyl ester, VDC 1101

Beschreibung

Rabacfosadine is a novel antiviral drug that has been shown to be effective in the treatment of HIV. It is a potent inhibitor of viral DNA synthesis and viral replication, which are essential for the production of new viruses. Rabacfosadine has also been shown to have antitumor activity against human cancer cells. This drug inhibits collagen production and causes cell death by apoptosis, which may lead to its use as an anti-inflammatory drug. Rabacfosadine blocks viral DNA synthesis and replication by inhibiting the enzyme DNA polymerase, preventing the production of new viruses. The clinical response of rabacfosadine to HIV treatment is statistically significant with a number of clinical trials showing positive results. Rabacfosadine is also used in the treatment of herpes simplex virus infections and lymphocytic leukemia. Chronic lymphocytic leukemia patients are given rabacfosadine as part of their chemotherapy regimen, along with tenofovir

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 526.5 g/mol
• Formel: C₂₁H₃₅N₈O₆P
• Reinheit: Min. 95%